Addictions, Drug & Alcohol Institute


March 1, 2021

Putting People First: The Why Behind ADAI’s Name Change

by ADAI Director Susan Ferguson, PhD ADAI was founded in 1973 with the goal of improving the lives of individuals and communities affected by substance use and addiction. Unfortunately, substance use and substance use disorders have long been stigmatized in our society. This, in turn, can be a major barrier for seeking and receiving medical or…

New Methamphetamine Overdose Materials & Report

top of meth flyer with words Methamphetamine: Stay Safe, Stay Alive

ADAI and have several new materials available related to methamphetamine overdose and overamping. Report: Acute Consequences of Methamphetamine Use Among Participants of Syringe Services Programs Drug overdose deaths involving methamphetamine have risen over 600% in the last decade. The 2019 Washington State Syringe Exchange Health Survey asked syringe services program participants about nonfatal, acute consequences of…

February 10, 2021

Washington’s Overdose Deaths Increase Sharply: Fentanyl Availability a Factor

Caleb Banta-Green

In this interview with KUOW, ADAI Principal Research Scientist Caleb Banta-Green, PhD, MPH, MSW, describes a striking increase in drug overdoses in the first half of 2020 and continuing on into the year. Fentanyl’s increasing availability, typically sold as what looks like prescription Oxycodone pills, is a major contributing factor. “The issue is that because…

February 5, 2021

Q&A with Dr. Caleb Banta-Green: Fentanyl’s Growth Among Overdoses “Stunning”

Drug poisonings graph from data page

In late December, the Centers for Disease Control and Prevention reported that 81,230 Americans had died from a drug overdose in the year that ended in May 2020 — the highest total ever for a 12-month span. The report largely attributed the rise to illegally manufactured fentanyl, an opioid often found in counterfeit oxycodone pills….

February 4, 2021

ADAI’s Marijuana Research, Outreach, and Education Work, 2019-2021

group of people around a globe

The ADAI Cannabis Workgroup carries out research, outreach, and education projects that respond to emerging needs of Washingtonians in the context of legalized cannabis, with the goal of helping agencies, policymakers, and individuals make decisions and set priorities. Our 2019-2021 Interim Marijuana Research Report describes the studies, collaborative work, and information products completed during the 2019-2021 biennium…

February 5, 2020

Jail-Based Intervention Increases Post-Release Initiation of Medication Treatment for OUD

Incarcerated male sitting on bench

People with opioid use disorder (OUD) are frequently incarcerated and, as a result, jails house many individuals with OUD. OUD goes largely untreated during periods of incarceration. Additionally, the risk of relapse to opioid use, as well as opioid-induced overdose, is very high after release from incarceration, with former inmates having an approximately 10-fold higher…

February 3, 2020

Seattle to Distribute Naloxone Kits & Hold Trainings to Counter Fentanyl Overdoses

Narcan nasal spray

The city of Seattle will be distributing 700 naloxone kits and convening 25 training sessions with community organizations as part of an effort to counter overdoses caused by fentanyl. ADAI staff Alison Newman and Caleb Banta-Green provided input on the mayor’s plan and will be delivering many of the naloxone trainings. For more about this…

January 7, 2020

Kudos to Dennis Donovan!

This review co-authored by ADAI’s former director Dr. Dennis Donovan has been read online 5000 times – Well done! Marlatt GA, Baer JS, Donovan DM, Kivlahan DR (1988). Addictive behaviors: etiology and treatment. Annual Review of Psychology 39:223-52. If you want to read this article, request a copy from

December 23, 2019

King County’s “Bupe Pathways” Program is a National Model

A widely-reprinted national news story featured King County’s local “Bupe Pathways” program, which provides client-centered care and rapid access to medications that treat opioid use disorder. The quick access model that offers effective medications is gaining national attention. But finding a prescriber without a waiting list is difficult. Guidelines say bupe should be used alongside…

December 18, 2019

Noreen Balch Retires from ADAI and the UW

Noreen Balch retired from ADAI and the UW in December 2019, after working as ADAI’s Administrator since 2014. This photo shows Noreen with the ADAI directors she worked with during her time here: Dennis Donovan (L), Caleb Banta-Green, and ADAI’s current director Susan Ferguson (R). Thank you, and best wishes for a happy and fulfilling…

Next page